Latest Form 4 insider transactions

Gregory Westin Wendt, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Matthew Kalish, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Marni M Walden, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Jocelyn Moore, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Ryan R Moore, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Woodrow Levin, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Robert Mionis, Chief Executive Officer and a Director of Celestica Inc, sold 51,061 shares of common stock on August 5, 2026.

Harry Sloan, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Valerie Mosley, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Steven Joseph Murray, a Director of DraftKings Inc., received 10,588 shares of common stock on August 4, 2026.

Robert Mionis, Chief Executive Officer and a Director of Celestica Inc, sold 98,453 shares of common stock on August 4, 2026.

Mandeep Chawla, Chief Financial Officer of Celestica Inc, sold 16,117 shares of common stock on August 4, 2026.

Mika K Derynck, a Director of Enliven Therapeutics, Inc., sold 158,795 shares of common stock on August 4, 2026 for $60.21 per share.

Nathan O'Konek, General Counsel & Secretary of Firefly Aerospace Inc., received 103,154 shares of common stock on August 4, 2026.

Jack Bendheim and 1 other reported changes in beneficial ownership of Phibro Animal Health Corp common stock on August 4, 2026.

Lisa Ann Escudero, See Remarks of Phibro Animal Health Corp, reported a transaction in 265 shares of common stock on August 4, 2026.

Larry Lee Miller, Chief Operating Officer of Phibro Animal Health Corp, reported a transaction in 635 shares of common stock on August 4, 2026.

Judith Weinstein, See Remarks of Phibro Animal Health Corp, reported a transaction in 472 shares of common stock on August 4, 2026.

Glenn David, Chief Financial Officer of Phibro Animal Health Corp, reported a transaction in 840 shares of common stock on August 4, 2026.

Daniel M Bendheim, President and CEO and a Director of Phibro Animal Health Corp, reported a transaction in 486 shares of common stock on August 4, 2026.

Eagle Point Credit Management LLC and 1 other reported changes in beneficial ownership of ACRES Commercial Realty Corp. common stock on August 4, 2026.

Dennis L Triplett, a Director of Paysign, Inc., reported multiple transactions in common stock on August 4, 2026.

Jeffrey B Newman, a Director of Paysign, Inc., reported multiple transactions in common stock on August 4, 2026.

Bruce A Mina, a Director of Paysign, Inc., reported multiple transactions in common stock on August 4, 2026.

Daniel R Henry, a Director of Paysign, Inc., reported multiple transactions in common stock on August 4, 2026.

Nina Richardson, a Director of Cohu Inc, sold 3,055 shares of common stock on August 5, 2026 for $51.54 per share.

Peter O'Rourke, a Director of Mainz Biomed N.V., received 191,860 shares of common stock on July 22, 2026.

David Natan, a Director of Mainz Biomed N.V., received 191,860 shares of common stock on July 22, 2026.

William J Caragol, Chief Financial Officer of Mainz Biomed N.V., received 212,500 shares of common stock on July 22, 2026.

Andrew M Caggia, a Director of Cohu Inc, sold 15,252 shares of common stock on August 5, 2026.